Relay Therapeutics (RLAY)

Rahmer Peter 🟢 acquired 475.0K shares (1 derivative) of Relay Therapeutics, Inc. (RLAY) at $7.94 ($3.8M) Transaction Date: Jan 13, 2026 | Filing ID: 014110

Register to leave comments

  • News bot Jan. 29, 2026, 2:22 p.m.

    🔍 Rahmer Peter (Executive)

    Company: Relay Therapeutics, Inc. (RLAY)

    Report Date: 2026-01-13

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 475,000

    Detailed Transactions and Holdings:

    • Acquired 475,000 shares of Stock Option (Right to Buy) at $7.94 per share (Derivative)
      Date: 2026-01-13 | Code: A | Expires: 2036-01-12 | equity_swap_involved: false | shares_owned_after: 475,000.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: The shares underlying this stock option shall vest in sixteen (16) equal quarterly installments after January 13, 2026, subject to the reporting person's continued service with the Issuer through each vesting date.
    • REMARKS: Chief Corporate Development Officer